Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih

Journal of Physiology

Volumn 586, Issue 8, 2008, Pages 2157-2170

  Wanat, M J ^a,b   Hopf, F W ^b   Stuber, G D ^b   Phillips, P E M ^c   Bonci, Antonello ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CYCLIC AMP; DOPAMINE; HORMONE RECEPTOR STIMULATING AGENT; INWARDLY RECTIFYING POTASSIUM CHANNEL; PHOSPHOLIPASE C; POTASSIUM CHANNEL; PROTEIN KINASE C; VOLTAGE DEPENDENT ANION CHANNEL; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTAMATE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; APPETITE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; MOLECULAR MECHANICS; MOLECULAR MIMICRY; MOUSE; NERVE CELL STIMULATION; NEUROMODULATION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VENTRAL TEGMENTUM; ANIMAL EXPERIMENT; BRAIN REGION; DOPAMINE METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; HIPPOCAMPAL CA3 REGION; HYPERPOLARIZATION; IMMUNOREACTIVITY; PROTEIN CONTENT; PROTEIN FUNCTION; STIMULUS RESPONSE;

ACTION POTENTIALS; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; PATCH-CLAMP TECHNIQUES; PROTEIN KINASE C; VENTRAL TEGMENTAL AREA;

EID: 42149150944     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2007.150078     Document Type: Article

References (73)

1. Abercrombie ED, Keefe KA, DiFrischia DS & Zigmond MJ (1989). Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem 52, 1655-1658.
2. Aldenhoff JB, Gruol DL, Rivier J, Vale W & Siggins GR (1983). Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science 221, 875-877.
3. Anstrom KK & Woodward DJ (2005). Restraint increases dopaminergic burst firing in awake rats. Neuropsychopharmacology 30, 1832-1840.
4. Banki CM, Bissette G, Arato M, O'Connor L & Nemeroff CB (1987). CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am J Psychiatry 144, 873-877.
5. Beninger RJ (1983). The role of dopamine in locomotor activity and learning. Brain Res 287, 173-196.
6. Beninger RJ (2006). Dopamine and incentive learning: A framework for considering antipsychotic medication effects. Neurotox Res 10, 199-209.
7. Blanchard DC, Griebel G & Blanchard RJ (2003). The Mouse Defense Test Battery: Pharmacological and behavioral assays for anxiety and panic. Eur J Pharmacol 463, 97-116.
8. Blanchard RJ, Kaawaloa JN, Hebert MA & Blanchard DC (1999). Cocaine produces panic-like flight responses in mice in the mouse defense test battery. Pharmacol Biochem Behav 64, 523-528.
9. Blank T, Nijholt I, Grammatopoulos DK, Randeva HS, Hillhouse EW & Spiess J (2003). Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: Role in neuronal excitability and associative learning. J Neurosci 23, 700-707.
10. Borgland SL, Taha SA, Sarti F, Fields HL & Bonci A (2006). Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49, 589-601.
11. Cagniard B, Balsam PD, Brunner D & Zhuang X (2006). Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward. Neuropsychopharmacology 31, 1362-1370.
12. Cameron DL, Wessendorf MW & Williams JT (1997). A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids. Neuroscience 77, 155-166.
13. h) in the rat substantia nigra pars compacta implicates the protein kinase C pathway. J Physiol 503, 87-97.
14. Contarino A, Dellu F, Koob GF, Smith GW, Lee KF, Vale WW & Gold LH (2000). Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice. Endocrinology 141, 2698-2702.
15. + -ATPase in the choroid plexus. Regulation by serotonin/protein kinase C pathway. J Biol Chem 270, 2427-2430.
16. Fogle KJ, Lyashchenko AK, Turbendian HK & Tibbs GR (2007). HCN pacemaker channel activation is controlled by acidic lipids downstream of diacylglycerol kinase and phospholipase A2. J Neurosci 27, 2802-2814.
17. Ford CP, Mark GP & Williams JT (2006). Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci 26, 2788-2797.
18. h) in central neurons. Eur J Neurosci 12, 2685-2693.
19. Frere SG, Kuisle M & Luthi A (2004). Regulation of recombinant and native hyperpolarization-activated cation channels. Mol Neurobiol 30, 279-305.
20. Funk CK, Zorrilla EP, Lee MJ, Rice KC & Koob GF (2007). Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry 61, 78-86.
21. Gershon AA, Vishne T & Grunhaus L (2007). Dopamine D2-like receptors and the antidepressant response. Biol Psychiatry 61, 145-153.
22. Grace A & Onn SP (1989). Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J Neurosci 9, 3463-3481.
23. Griebel G, Perrault G & Sanger DJ (1998). Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology (Berl) 138, 55-66.
24. + channel-mediated dampening of dopamine neuron excitability by the antipsychotic drug haloperidol. J Neurosci 23, 10859-10866.
25. + current, I sAHP, by the neuropeptides CRF, VIP, and CGRP in hippocampal pyramidal neurons. J Neurophysiol 83, 2071-2079.
26. Hauger RL, Risbrough V, Brauns O & Dautzenberg FM (2006). Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: New molecular targets. CNS Neurol Disord Drug Targets 5, 453-479.
27. Horger BA & Roth RH (1996). The role of mesoprefrontal dopamine neurons in stress. Crit Rev Neurobiol 10, 395-418.
28. Inglis FM & Moghaddam B (1999). Dopaminergic innervation of the amygdala is highly responsive to stress. J Neurochem 72, 1088-1094.
29. Jedema HP, Finlay JM, Sved AF & Grace AA (2001). Chronic cold exposure potentiates CRH-evoked increases in electrophysiologic activity of locus coeruleus neurons. Biol Psychiatry 49, 351-359.
30. Jedema HP & Grace AA (2004). Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro. J Neurosci 24, 9703-9713.
31. Johnson SW & North RA (1992). Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol 450, 455-468.
32. Kalivas PW, Duffy P & Latimer LG (1987). Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther 242, 757-763.
33. Kash TL & Winder DG (2006). Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 51, 1013-1022.
34. Kauer JA (2004). Learning mechanisms in addiction: Synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annu Rev Physiol 66, 447-475.
35. Koob GF (1999). Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry 46, 1167-1180.
36. Korotkova TM, Brown RE, Sergeeva OA, Ponomarenko AA & Haas HL (2006). Effects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat. Eur J Neurosci 23, 2677-2685.
37. + current of dopamine and GABA neurons in the ventral tegmental area. J Neurophysiol 96, 544-554.
38. Kuryshev YA, Haak L, Childs GV & Ritchie AK (1997). Corticotropin releasing hormone inhibits an inwardly rectifying potassium current in rat corticotropes. J Physiol 502, 265-279.
39. Lacey MG, Mercuri NB & North RA (1987). Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J Physiol 392, 397-416.
40. Lavicky J & Dunn AJ (1993). Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem 60, 602-612.
41. + channels in dendritic inhibitory interneurones of rat hippocampus. J Physiol 538, 405-419.
42. Liu J, Yu B, Orozco-Cabal L, Grigoriadis DE, Rivier J, Vale WW, Shinnick-Gallagher P & Gallagher JP (2005). Chronic cocaine administration switches corticotropin-releasing factor 2 receptor-mediated depression to facilitation of glutamatergic transmission in the lateral septum. J Neurosci 25, 577-583.
43. h) in ventral tegmental area dopamine neurons: Involvement of 5-HT2 receptors and protein kinase C. J Neurophysiol 90, 3201-3212.
44. Lodge DJ & Grace AA (2005). Acute and chronic corticotropin-releasing factor 1 receptor blockade inhibits cocaine-induced dopamine release: Correlation with dopamine neuron activity. J Pharmacol Exp Ther 314, 201-206.
45. McFarland K, Davidge SB, Lapish CC & Kalivas PW (2004). Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J Neurosci 24, 1551-1560.
46. Magee JC (1998). Dendritic hyperpolarization-activated currents modify the integrative properties of hippocampal CA1 pyramidal neurons. J Neurosci 18, 7613-7624.
47. Margolis EB, Lock H, Hjelmstad GO & Fields HL (2006). The ventral tegmental area revisited: Is there an electrophysiological marker for dopaminergic neurons? J Physiol 577, 907-924.
48. h channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. J Neurosci 22, 1290-1302.
49. Pecina S, Schulkin J & Berridge KC (2006). Nucleus accumbens corticotropin-releasing factor increases cue-triggered motivation for sucrose reward: Paradoxical positive incentive effects in stress? BMC Biol 4, 8.
50. Phillips PE, Walton ME & Jhou TC (2007). Calculating utility: preclinical evidence for cost-benefit analysis by mesolimbic dopamine. Psychopharmacology (Berl) 191, 483-495.
51. H in rat hypothalamic paraventricular nucleus parvocellular neurons in vitro. J Neurophysiol 94, 226-234.
52. Raes A, Wang Z, van den Berg RJ, Goethals M, Van de Vijver G & van Bogaert PP (1997). Effect of cAMP and ATP on the hyperpolarization-activated current in mouse dorsal root ganglion neurons. Pflugers Arch 434, 543-550.
53. Rose RM (1987). Neuroendocrine effects of work stress. In Work Stress: Health Care Systems in the Workplace, ed. Quick JC, Bhagal RS, Dalton JE & Quick JD, pp. 130-147. Praeger, New York.
54. + currents in neurones: Types, physiological roles and modulation. Trends Neurosci 19, 150-154.
55. Sajdyk TJ, Schober DA, Gehlert DR & Shekhar A (1999). Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav Brain Res 100, 207-215.
56. Salamone JD (1996). The behavioral neurochemistry of motivation: methodological and conceptual issues in studies of the dynamic activity of nucleus accumbens dopamine. J Neurosci Meth 64, 137-149.
57. Sarnyai Z, Shaham Y & Heinrichs SC (2001). The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev 53, 209-243.
58. h) in retinal rod photoreceptors. Neuropharmacology 39, 1284-1291.
59. Tan H, Zhong P & Yan Z (2004). Corticotropin-releasing factor and acute stress prolongs serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons. J Neurosci 24, 5000-5008.
60. Tidey JW & Miczek KA (1996). Social defeat stress selectively alters mesocorticolimbic dopamine release: An in vivo microdialysis study. Brain Res 721, 140-149.
61. Tozzi A, Bengtson CP, Longone P, Carignani C, Fusco FR, Bernardi G & Mercuri NB (2003). Involvement of transient receptor potential-like channels in responses to mGluR-I activation in midbrain dopamine neurons. Eur J Neurosci 18, 2133-2145.
62. + channel in acutely dissociated rat substantia nigra neurones. Neuropharmacology 39, 191-201.
63. Ungless MA, Singh V, Crowder TL, Yaka R, Ron D & Bonci A (2003). Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron 39, 401-407.
64. Valdez GR (2006). Development of CRF1 receptor antagonists as antidepressants and anxiolytics: Progress to date. CNS Drugs 20, 887-896.
65. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W & Sawchenko PE (2000). Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428, 191-212.
66. Wang B, Shaham Y, Zitzman D, Azari S, Wise RA & You ZB (2005). Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: A role in stress-induced relapse to drug seeking. J Neurosci 25, 5389-5396.
67. Werner P, Hussy N, Buell G, Jones KA & North RA (1996). D2, D3, and D4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes. Mol Pharmacol 49, 656-661.
68. Winsky-Sommerer R, Boutrel B & de Lecea L (2005). Stress and arousal: The corticotrophin-releasing factor/hypocretin circuitry. Mol Neurobiol 32, 285-294.
69. Wise RA (2004). Dopamine, learning and motivation. Nat Rev Neurosci 5, 483-494.
70. Yang M, Farrokhi C, Vasconcellos A, Blanchard RJ & Blanchard DC (2006). Central infusion of ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB). Behav Brain Res 171, 1-8.
71. Zhou QY & Palmiter RD (1995). Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83, 1197-1209.
72. Zolles G, Klocker N, Wenzel D, Weisser-Thomas J, Fleischmann BK, Roeper J & Fakler B (2006). Pacemaking by HCN channels requires interaction with phosphoinositides. Neuron 52, 1027-1036.
73. Zong X, Eckert C, Yuan H, Wahl-Schott C, Abicht H, Fang L, Li R, Mistrik P, Gerstner A, Much B, Baumann L, Michalakis S, Zeng R, Chen Z & Biel M (2005). A novel mechanism of modulation of hyperpolarization-activated cyclic nucleotide-gated channels by Src kinase. J Biol Chem 280, 34224-34232.